Brief: First data generated in US Support Theraclion's echotherapy system
Aug 31 (Reuters) - Theraclion SA ALTHER.PA :
* First data generated in US Support Theraclion's echotherapy system
* FDA provides clearance to initiate 100-patient ide study for breast fibroadenoma
* Echopulse achieved positive clinical results in 5 studies from US, Europe and Asia for
treatment of breast fibroadenoma and benign symptomatic thyroid nodules
Source text for Eikon: ID:nBw9wb3Nja
Further company coverage: ALTHER.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Theraclion SA
See all newsBrief: Theraclion Appoints Claude Lenoir As Interim Chairman
Brief: Theraclion Secures U.S. Reimbursement Milestone for Sonovein With New Category III CPT Code
French and Benelux stocks-Factors to watch
Brief: Inner Mongolia Furui Medical Raises Stake In Theraclion
Brief: French medical technology company Theraclion strikes partnership with Chinese company Furui and names new CEO